Hypertensive Medications in Competitive Athletes

Area of Science:

• Cardiovascular Medicine
• Sports Medicine
• Hypertension Research

Background:

• Hypertension is the most prevalent cardiovascular disease in athletes, posing significant long-term health risks.
• Despite fitness, athletes are susceptible to hypertension-related morbidity and mortality.
• Secondary hypertension causes, including substance abuse and medical conditions, require critical evaluation.

Purpose of the Study:

• To outline management strategies for hypertension in athletes.
• To identify lifestyle factors and secondary causes of hypertension.
• To recommend appropriate pharmacologic treatments with minimal performance impact.

Main Methods:

• Review of existing literature on hypertension management in athletic populations.
• Emphasis on identifying and addressing secondary causes of hypertension.
• Guideline recommendations for pharmacologic treatment and athletic participation.

Main Results:

• Management options exist to mitigate risks with minimal athletic performance impact.
• First-line medications include ACE inhibitors, angiotensin II receptor blockers (ARBs), and calcium channel blockers (CCBs).
• Close monitoring of blood pressure response is essential for adequate control.

Conclusions:

• Effective management of hypertension in athletes is achievable through lifestyle adjustments and targeted medications.
• Athletes with stage 2 or severe stage 1 hypertension should restrict participation in high-dynamic load sports.
• Early identification and treatment of secondary hypertension are crucial for long-term athlete health.